Effect of cyclosporin A and Tacrolimus on sister chromatid exchange frequency in renal transplant patients

Genetic Testing

Volumn 12, Issue 3, 2008, Pages 427-430

  Öztürk, Şükrü ^a   Ayna, Tülay K ^a   Çefle, Kivanç ^a   Palanduz, Şükrü ^a   Çiftçi, Hayriye Ş ^a   Kaya, Selvi A ^a   Diler, A Sarper ^a   Türkmen, Aydin ^a   Gürtekin, Mehmet ^a   Sever, Mehmet Şükrü ^a   Çarin, Mahmut ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENOTOXICITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MALE; NEPHROTOXICITY; NEUROTOXICITY; PATIENT MONITORING; SISTER CHROMATID EXCHANGE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SISTER CHROMATID EXCHANGE; TACROLIMUS; YOUNG ADULT;

EID: 51049090145     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2008.0006     Document Type: Article

References (36)

1. Abbas AK, Lichtman AH, Pober JS (1994) Immune responses to tissue transplants. In: Cellular and Molecular Immunology, Second edition. W.B. Saunders Company, Philadelphia, pp 339-343.
2. Anaya F, Plaza J, Sanz-Guajardo D, et al. (2003) Cancer after renal transplantation. Transplant Proc 35(2):697-699.
3. Bajnoczky K, Meggyessy V, Mehes K (1980) Cytogenet investigations in prednisolone treated infants. Acta Paediatr Acad Sci Hung 21(2-3):139-143.
4. Barale R, Chelotti L, Davini T, et al. (1998) Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1,650 subjects in an Italian population: II. Contribution of sex, age, and lifestyle. Environ Mol Mutagen 31(3):228-242.
5. Beveridge T, Kruup P, McKibbin C (1984) Letters to the editor: lymphomas and lymphoproliferative lesions developing under cyclosporine therapy. Lancet 1:788.
6. Borel JF (1981) Cyclosporin A: present experimental studies. Tranplant Proc 13:344-348.
7. Brown T, Dawson AA, King DJ, et al. (1986) Variation of SCE frequency in lymphocyte cultures from patients with Hodgkin's disease before, during, and after treatment. Cancer Genet Cytogenet 20(1-2):53-61.
8. Carbonell E, Peris F, Xamena N, et al. (1995) SCE analysis in human lymphocytes of a Spanish control population. Mutat Res 335:35-34.
9. Carrano AV, Moore DH (1982) The rationale methodology for quantifying sister-chromatid exchanges in humans. In: Heddle JA (ed) New Horizons in Genetic Toxicology. New York, Academic Press, pp 267-304.
10. Dass BC (1988) Factors that influence formation of sister chromatid exchanges in human blood lymphocytes. CRC Crit Rev Toxicol 19:43-86.
11. Dean BJ, Danford N (1984) Assays for the detection of chemically induced chromosome damage in cultured mammalian cells. In: Venitt S, Parry JM (eds) Mutagenicity Testing. A Practical Approach. Oxford, Oxford University Press, pp 187-232.
12. Evans HJ (1977) What are the sister chromatid exchanges? Chromosomes Today 6:315-326.
13. Frayha HH, Nazer H, Kalloghlian A, et al. (1991) Lymphoproliferative disorder in a liver transplant patient on FK506. Lancet 337:296-297.
14. Gebhart E (1981) Sister chromatid exchanges and structural chromosome aberration in mutagenicity testing. Hum Genet 58:235-254.
15. Hiraoka A, Ohashi Y, Okamoto S, et al.; The Japanese FK506 BMT (Bone Marrow Transplantation) Study Group (2001) Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant 28(2):181-185.
16. Japanese FK-506 Study Group (1991) Japanese study of FK506 on kidney transplantation the benefit of monitoring the whole blood FK506 concentration. Transplant Proc 23:3085-3088.
17. Kelly GE, Sheil AG (1983) Sister chromatid exchange in lymphocytes from renal transplant recipients with and without cancer. Br J Cancer 48(6):797-801.
18. Kitahara S, Makuuchi M, Kawasaki S, et al (1991) Lymphoproliferative disorders after FK506. Lancet 337:123-128.
19. Konuk N (1997) Graft Versus Host Hastaliǧi. Klinik Gelişim 10:57-59.
20. Mertens R, Bussing A, Rubbert F, et al. (1996) SCE rate and lymphocyte differentiation in children with acute lymphoblastic leukemia and SCE rates of leukemia patients in long-term remission. Klin Padiatr 208(2):73-76.
21. Mistrikova J, Mrmusova M, Durmanova V, Rajcani J (1999) Increased neoplasm development due to immunosuppressive treatment with FK-506 in BALB/C mice persistently infected with the mouse herpesvirus (MHV-72). Viral Immunol 12(3):237-247.
22. Nakanishi Y, Schneider EL (1979) In vivo sister-chromatid exchange: a sensitive measure of DNA damage. Mutat Res 60:329-337.
23. Oliveira VD, Zankl H, Rath T (2004) Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures. Exp Clin Transplant 2(2):273-279.
24. Ozturk S, Palandüz S, Aktan M, et al. (2000) Sister chromatid exchange frequency in B-cells stimulated by TPA in chronic lymphocytic leukemia. Cancer genet Cytogenet 123(1):49-51.
25. Palanduz Ş, Sever MŞ, Öztürk Ş, et al. (1999) Genotoxic potential of cyclosporin A in patients with renal transplantation. Cell Biol Toxicol 15:13-17.
26. Pen I (1993) Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 12:328-336.
27. Penn L (1983) Lymphomas complicating organ transplantation. Transplant Proc 15:2790-2796.
28. Rowland RE, Harding KM (1999) Increased sister chromatid exchange in the peripheral blood lymphocytes of young women who smoke cigarettes. Hereditas 131(2):143-146.
29. Roy First M (1997) An update on new immunosuppressive drugs undergoing preclinical and clinical trials: potential applications in organ transplantation. Am J Kidney Dis 29(2):303-317.
30. Sardas S, Erdoǧan F, Sardas OS, et al. (1994) Sister chromatid exchange studies for monitoring DNA damage in lymphocytes of malignant lymphoma patients under cytostatic therapy. Anticancer Drugs 5(4):487-489.
31. Speek WT, Rosenkranz HS (1976) Mutagenicity of azathioprine. Cancer Res 36:108-112.
32. Stuart LS, Gerald RC (1992) The mechanism of action of cyclosporin A and FK 506. Immunol Today 13:137-141.
33. Tuna M, Artan S, Gezer S, et al. (1995) Sister chromatid exchange analysis in acute leukemia patients. Cancer Genet Cytogenet 79(1):86-88.
34. Yoshimura N, Oka T (1990) FK506, a new immunosuppressive agent: a review. J Immunol Immunopharmacol 10:32-36.
35. Yuzawa K, Kando I, Fukao K, et al. (1986) Induction of sister chromatid exchange in human cell. Transplantation 42(1):61-63.
36. Zwanenburg TS, Suter W, Matter BE (1988) Absence of genotoxic potential for cyclosporine in experimental systems. Transplant Proc 20(2):435-437.